Marker Therapeutics Reports Year-End 2023 Corporate and
Lead program in patients with lymphoma demonstrated preliminary safety and efficacy results with sustained complete response in first study participant...
Source: globenewswire.com
Stay updated with breaking news from Monic Stuart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lead program in patients with lymphoma demonstrated preliminary safety and efficacy results with sustained complete response in first study participant...
Marker Therapeutics initiated APOLLO trial for the treatment of lymphoma patients who have relapsed after anti-CD19 CAR T therapy in the first quarter of...
Accomplished healthcare executive brings extensive drug development and regulatory experience from global pharmaceutical companies to Marker Therapeutics...